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compared with urban patients in an elective setting (p<0.001). Emergency
patients presented at a signiﬁcantly older age compared to elective pa-
tients (p¼0.004).
Conclusions: a one stop UGI cancer clinic could reduce travel distance for
rural patients, potentially improving care and patient satisfaction.
0998: POSITRON EMISSION TOMOGRAPHY IN OESOPHAGEAL CANCER
STAGING: A TAILORED APPROACH
David Bunting *, Wesley Lai, Grant Sanders. Derriford Hospital, Plymouth,
UK.
Introduction: The authors aim to re-evaluate the role of PET-CT in the
staging of oesophageal cancer (OC). They investigate whether it is possible
to identify a group of patients on the basis of endoscopy and CT ﬁndings
that can safely be spared from this investigation.
Methods: Consecutive patients undergoing PET-CT scan for the staging of
localised OC diagnosed between 2010 and 2013 were identiﬁed from a
specialist MDT database. Without knowledge of the PET-CT result, patients
were stratiﬁed into low-risk or high-risk groups according to the likeli-
hood of identifying metastatic disease on PET-CT based on speciﬁed CT/
endoscopy criteria.
Results: In 385 undergoing PET-CT, metastatic disease was identiﬁed in
52(13.5%) patients. All 52 patients had been correctly stratiﬁed as high-risk
according to the criteria. 112 patients were stratiﬁed as low-risk and 273 as
high-risk. Mean time from diagnosis surgery was 68.6 days which
compared to 49.6 days in a separate group of patients not undergoing PET-
CT (p¼0.04).
Conclusions: In one of the largest studies to date, the authors have
introduced a new classiﬁcation that can accurately stratify patients ac-
cording to the risk of having metastatic disease. This could be used to avoid
unnecessary PET-CT in 33% of patients.
1048: STAGING LAPAROSCOPY IN OESOPHAGO-GASTRIC CANCER: A
TAILORED APPROACH
David Bunting *, Wesley Lai, Andrei Tanase, Grant Sanders. Derriford
Hospital, Plymouth, UK.
Introduction: The authors aim to re-evaluate the role of staging laparos-
copy (SL) in the management of oesophago-gastric cancer and investigate
whether it is possible to identify a group of patients on the basis of
endoscopy and CT ﬁndings that will not beneﬁt and can be spared from
this investigation.
Methods: Consecutive patients undergoing SL in the work-up of localised
oesophago-gastric cancer between 2010 and 2013 were identiﬁed from a
specialist MDT database. Without knowledge of the SL result, patients
were stratiﬁed into low-risk or high-risk groups according to the likeli-
hood of operability based on speciﬁc endoscopy/CT criteria.
Results: Of 193 patients undergoing SL, 28(15%) were found to have
inoperable disease at SL. All 28 cases identiﬁed at SL had been correctly
stratiﬁed as high-risk. 42 patients were predicted as low risk and 151 as
high risk. None of the low risk patients went on to have inoperable disease
at SL or laparotomy.
Conclusions: A proposed classiﬁcation based on initial endoscopy and CT
ﬁndings is able to identify a group of patients at low risk of having
inoperable disease. This group, representing 25% of the cases subse-
quently deemed resectable on SL could have safely been spared the
procedure.
1202: BIODEGRADABLE OESOPHAGEAL STENTS IN THE MANAGEMENT
OF BENIGN AND MALIGNANT OESOPHAGEAL STRICTURES
Stephen McCain *, Scott McCain, Barry Quinn, Ronan Gray, Paul Rice.
Craigavon Area Hospital, Craigavon, UK.
Introduction: Biodegradable oesophageal stents are used in the man-
agement of refractory benign oesophageal strictures and malignant stric-
tures which may proceed to surgery. Our aimwas to review the safety and
efﬁcacy of biodegradable oesophageal stents in the management of benign
and malignant strictures.
Methods: Patients were identiﬁed using hospital coding data and radi-
ology PACS. Charts and hospital databases were retrospectively reviewed.
Data collected included patient demographics and outcomes. Dysphagia
was graded using the Mellow and Pinkas dysphagia grading scale.Results: Stents were deployed successfully in 29 of 30 attempts. 17 stents
were inserted for benign and 12 for malignant disease. Pre and post pro-
cedure swallowing scores were recorded for 27 procedures and resulted in
a mean improvement (2.88-1.15 p<0.002). One patient experienced tran-
sient chest pain. No serious complications occurred. There was no mor-
tality at 30 days. 3 patients progressed to oesophagectomy with no
anastomotic leaks in this group. 4 patients required repeat biodegradable
stenting (mean 273 days). 5 patients with malignancy proceeded to metal
stent insertion (mean 51 days).
Conclusions: Biodegradable stent insertion is a safe and efﬁcacious
method of treating oesophageal strictures, limiting repeat intervention in
benign disease and allowing nutrition during staging of malignancy. There
were no increased surgical complications at oesophagectomy.
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0108: CORRELATION OF CLINICAL DIAGNOSIS VS URODYNAMIC DIAG-
NOSIS IN THE MANAGEMENT OF URINARY INCONTINENCE
Binu M.K. Thomas 1,*, Siobhan Woolsey 2. 1Causeway Hospital, Coleraine, UK;
2Belfast City Hospital, Belfast, UK.
Introduction: The need for Urodynamics in the diagnosis of lower urinary
tract has been a topic fordebate for a long time. Even though it has improved
the knowledge of the pathophysiology of lower urinary tract dysfunction,
many are still reluctant to use this. The opinions for and against routine use
of Urodynamics varies among clinicians. In our studywe aim to evaluate the
usefulness of urodynamics in the management of urinary incontinence.
Method: 100 patients who underwent Urodynamics were selected and
Urodynamic diagnoses were compared with their clinical diagnosis based
on their symptoms to determine if there was any correlation between the
two.
Results: Of the 100 patients, 66 complained of urge incontinence and of
these, 35 were found to have detrusor over activity on Urodynamics. The
remaining 31 did not have urodynamically demonstrated urge inconti-
nence. 4 Patients who complained of urge incontinence were actually
found to have urodynamically proven stress incontinence. Among the 34
who did not complain of urge incontinence, 3 were found to have uro-
dynamically proven detrusor over activity (8.8%).
Conclusions: The well known saying of Blaivas - ' bladder is an unreliable
witness ' still hold true and Urodynamic study was found to play a vital role
in the assessment of lower urinary tract dysfunction.
0116: THE MANAGEMENT OF URETERIC STONES IN THE EMERGENCY
DEPARTMENT
Kirsty Dawson *, Tharani Nitkunan, Nasr Arsanious, Lindsay Dawson.
Croydon University Hospital, London, UK.
Introduction: To develop a proforma detailing speciﬁc criteria regarding
which patients with ureteric stones require admission and which patients
can be safely discharged. Therefore, limiting unnecessary bed days and
improving patient safety.
Methods: Data was collected prospectively for patients over 18 years, with
image proven ureteric stones at Croydon University Hospital over 2 month
periods; initially September-October 2012 and again August-September
2013, following the introduction of the proforma in December 2012. Pa-
rameters reviewed included patient epidemiological factors, imaging,
observations, blood results and patient outcome (i.e. whether the patient
had been admitted or discharged). The outcomes for patients were
deemed appropriate or inappropriate using the British Association of
Urological Surgeons (BAUS) guidelines.
Results: In the initial study, 28 patients met the inclusion criteria, of these,
22 patients (78.6%) had appropriate outcomes and 6 patients (21.4%) had
inappropriate outcomes. In the repeat study following the implementation
of the proforma, 21 patients met the inclusion criteria, of these, 18 (85.6%)
patients had appropriate outcomes and 3 patients (14.35) had inappro-
priate outcomes.
Conclusions: The introduction of a proforma with speciﬁc criteria for
admission has caused a reduction in unnecessary bed-days and improved
patient safety by reducing the number of inappropriate discharges.
0125: RAISED PSA: IS THE PROSTATE BIG, BAD, OR BOTH?
Dafydd Loughran *. Wrexham Maelor Hospital, Wales, UK.
